James B. Tananbaum, 10% Owner at Aimmune Therapeutics, Inc. (AIMT), sold 120,000 shares at $15.23 ($1.8M) on 2016-05-31, disclosed to the SEC on 2016-06-02.
Open-market sale of $1.8M AIMT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALMS | BUY | 2025-11-25 | $1.1M | — | Filing → |
| ALMS | BUY | 2025-11-19 | $3.8M | — | Filing → |
| ALMS | BUY | 2025-05-06 | $202K | — | Filing → |